DGF Investimentos

DGF Investimentos is a Sao Paulo-based veteran Brazilian VC firm focused on B2B software and technology services, with one of the longer histories in the Brazilian VC market, writing Series A and Series B checks in the $1M to $5M range. The fund’s positioning is institutional and B2B-oriented, with relevant healthcare surfaces including health IT software, hospital and clinic operations technology, payer-side analytics, and AI applications layered onto Brazilian provider and payer data. Founders pursuing pure consumer wellness, biotech, or care delivery brick-and-mortar should look elsewhere. The right founder is a Brazilian technical or commercial operator with a credible B2B product, real revenue at meaningful scale, and a path to category leadership in Brazilian health IT or expansion into broader LatAm. DGF is most useful when the founder has worked through Pre-Seed and Seed and is building toward Series A and B with disciplined unit economics. Geographic advantage is the deep Brazilian B2B technology network, multi-vintage pattern recognition across Brazilian software cycles, and connectivity into Brazilian Tier-1 follow-on capital and US Series B leads. Best entry is a warm intro from a portfolio founder, a Brazilian Tier-1 Seed fund that has co-invested with DGF, or a banker-introduced process for later-stage rounds. The team is relatively small and selective, so cold inbound conversion is lower. Lead the pitch with revenue, gross retention, sales-cycle data, and a credible regional expansion plan. Be explicit about LGPD posture, ANS dynamics where relevant, and how AI quality is monitored in production for clinical-adjacent products. Caveats: DGF’s multi-vintage track record means founders should diligence the firm’s current vintage, remaining deployment runway, and team continuity carefully, since multi-decade firms often have generational transitions in leadership. Brazilian healthcare’s payer concentration in operadoras like Bradesco Saude, Hapvida, and SulAmerica means a single contract decision can swing a year of revenue, and savvy investors model that risk explicitly. Ask DGF about reserves, prorata behavior, and which Series B and C leads have followed it into healthcare portfolio companies. Reference checks with current portfolio CEOs on operating support, commercial introductions, and behavior in hard rounds are particularly worth the time given the fund’s longer history. Used appropriately, DGF is a credible institutional Brazilian B2B partner for health IT founders at Series A and B; for sector-specialist healthcare conviction, founders may find sharper fit elsewhere.